AI Verdict
NATL has stronger fundamentals based on our AI analysis.
NATL vs NAMSW Fundamental Comparison
| Metric | NATL | NAMSW |
|---|---|---|
| Revenue | $4.4B | $22.5M |
| Net Income | $162.0M | $-203.8M |
| Net Margin | 3.7% | -905.7% |
| ROE | 40.2% | -29.8% |
| ROA | 2.9% | -26.5% |
| Current Ratio | 0.96x | 7.88x |
| Debt/Equity | 6.63x | 0.00x |
| EPS | $2.14 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NATL vs NAMSW: Frequently Asked Questions
Is NATL or NAMSW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NATL has stronger fundamentals. NATL is rated SELL (78% confidence) while NAMSW is rated STRONG SELL (88% confidence). This is not investment advice.
How does NATL compare to NAMSW fundamentally?
NCR Atleos Corp has ROE of 40.2% vs NewAmsterdam Pharma Co N.V.'s -29.8%. Net margins are 3.7% vs -905.7% respectively.
Which stock pays higher dividends, NATL or NAMSW?
NATL has a dividend yield of N/A or no dividend while NAMSW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NATL or NAMSW for long term?
For long-term investing, consider that NATL has SELL rating with 78% confidence, while NAMSW has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NATL vs NAMSW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NATL vs NAMSW, the AI consensus favors NATL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.